Glial Progenitor Cell–Based Treatment and Modeling of Neurological Disease
Year: 2012
Type: review
Abstract: The diseases of myelin are among the most prevalent and disabling conditions in neurology. These diseases include both the vascular and inflammatory demyelinating disorders of adulthood, as well as the childhood leukodystrophies and cerebral palsy. These fundamentally glial disorders may be amenable to treatment by glial progenitor cells (GPCs), which give rise to astroglia and myelin-producing oligodendrocytes. Given the development of new methods for generating and isolating human GPCs, the myelin disorders may now be compelling targets for cell-based therapy. In addition, the efficient engraftment and expansion of human GPCs in murine hosts has led to the development of human glial chimeric mouse brains, which provides new opportunities for studying the species-specific roles of human glia in cognition, as well as in disease pathogenesis.
Source: Science
Institution: University of Rochester Medicine
Language: English
Subfield: Developmental Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: The glymphatic system, a new concept in glia biology, Failure of metabolite clearance in a model of multi-lacunar infarcts, ATP as the instigator of inflammatory responses to spinal cord injury, Regulation of adult human oligodendrocyte progenitors, Molecular Regulation of Human Glial Progenitor Cell-Based Remyelination
OpenAlex ID: W2026547662
